ID   M10K
AC   CVCL_8100
DR   Cosmic; 733821
DR   Cosmic; 933013
DR   IARC_TP53; 23628
DR   Wikidata; Q54903457
RX   CelloPub=CLPUB00243;
RX   PubMed=1568228;
RX   PubMed=2323006;
RX   PubMed=11283936;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   CelloPub=CLPUB00243;
RA   Kahlos K.;
RT   "The expression and possible role of manganese superoxide dismutase in
RT   malignant pleural mesothelioma.";
RL   Thesis PhD (1999); University of Oulu; Oulu; Finland.
//
RX   PubMed=1568228;
RA   Metcalf R.A., Welsh J.A., Bennett W.P., Seddon M.B., Lehman T.A.,
RA   Pelin-Enlund K., Linnainmaa K., Tammilehto L., Mattson K., Gerwin B.I.,
RA   Harris C.C.;
RT   "p53 and Kirsten-ras mutations in human mesothelioma cell lines.";
RL   Cancer Res. 52:2610-2615(1992).
//
RX   PubMed=2323006; DOI=10.1093/carcin/11.4.673;
RA   Pelin-Enlund K., Husgafvel-Pursiainen K., Tammilehto L., Klockars M.,
RA   Jantunen K., Gerwin B.I., Harris C.C., Tuomi T., Vanhala E.,
RA   Mattson K., Linnainmaa K.;
RT   "Asbestos-related malignant mesothelioma: growth, cytology,
RT   tumorigenicity and consistent chromosome findings in cell lines from
RT   five patients.";
RL   Carcinogenesis 11:673-681(1990).
//
RX   PubMed=11283936; DOI=10.1002/1097-0142(20010401)91:7<1349::AID-CNCR1138>3.0.CO;2-D;
RA   Kahlos K., Soini Y., Sormunen R., Kaarteenaho-Wiik R., Paakko P.,
RA   Linnainmaa K., Kinnula V.L.;
RT   "Expression and prognostic significance of catalase in malignant
RT   mesothelioma.";
RL   Cancer 91:1349-1357(2001).
//